Randomised controlled trial of effect of whole soy replacement diet on features of metabolic syndrome in postmenopausal women: study protocol

Zhao-Min Liu, Suzanne Ho, Yuan-Tao Hao, Yu-Ming Chen, Jean Woo, Samuel Yeung-Shan Wong, Qiqiang He, Yao Jie Xie, Lap Ah Tse, Bailing Chen, Xue-Fen Su, Xiang-Qian Lao, Carmen Wong, Ruth Chan, Wen-Hua Ling, Zhao-Min Liu, Suzanne Ho, Yuan-Tao Hao, Yu-Ming Chen, Jean Woo, Samuel Yeung-Shan Wong, Qiqiang He, Yao Jie Xie, Lap Ah Tse, Bailing Chen, Xue-Fen Su, Xiang-Qian Lao, Carmen Wong, Ruth Chan, Wen-Hua Ling

Abstract

Introduction: Metabolic syndrome (MetS) is a public health problem in postmenopausal women. Whole soy foods are rich in unsaturated fats, high quality plant protein and various bioactive phytochemicals that may have a beneficial role in the management of MetS. The aim of the study is to examine the effect of whole soy replacement diet on the features of MetS among postmenopausal women.

Methods and analysis: This will be a 12-month, randomised, single-blind, parallel controlled trial among 208 postmenopausal women at risk of MetS or with early MetS. After 4 weeks' run-in, subjects will be randomly allocated to one of two intervention groups, whole soy replacement group or control group, each for 12 months. Subjects in the whole soy group will be required to include four servings of whole soy foods (containing 25 g soy protein) into their daily diet iso-calorically, replacing red or processed meat and high fat dairy products. Subjects in the control group will remain on a usual diet. The outcome measures will include metabolic parameters as well as a 10-year risk for ischaemic cardiovascular disease. We hypothesise that the whole soy substitution diet will notably improve features of MetS in postmenopausal women at risk of MetS or with early MetS. The study will have both theoretical and practical significance. If proven effective, the application of the whole soy replacement diet model will be a safe, practical and economical strategy for MetS prevention and treatment.

Ethics and dissemination: Ethics approval has been obtained from the Ethics Committee of the Chinese University of Hong Kong. The results will be disseminated via conference presentations and papers in academic peer reviewed journals. Data files will be deposited in an accessible repository.

Trial registration number: NCT02610322.

Keywords: metabolic syndromes; randomized controlled trial; replacement diet; whole soy.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Study flow of chart based on the CONSORT (Consolidated Standards of Reporting Trials) guidelines. MetS, metabolic syndrome.

References

    1. Knoops KT, de Groot LC, Kromhout D et al. . Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004;292:1433–9. 10.1001/jama.292.12.1433
    1. Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease. Food and Drug Administration, HHS. Final rule. Fed Regist 1999;64:57700–33.
    1. Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 2010;65:262–6. 10.1016/j.maturitas.2009.11.004
    1. Lao XQ, Ma WJ, Sobko T et al. . Dramatic escalation in metabolic syndrome and cardiovascular risk in a Chinese population experiencing rapid economic development. BMC Public Health 2014;14:983 10.1186/1471-2458-14-983
    1. Siu SC, Wong KW, Lee KF et al. . Prevalence of undiagnosed diabetes mellitus and cardiovascular risk factors in Hong Kong professional drivers. Diabetes Res Clin Pract 2012;96:60–7. 10.1016/j.diabres.2011.12.002
    1. Jenkins DJ, Mirrahimi A, Srichaikul K et al. . Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr 2010;140:2302S–11S. 10.3945/jn.110.124958
    1. Nettleton JA, Jebb S, Risérus U et al. . Role of dietary fats in the prevention and treatment of the metabolic syndrome. Ann Nutr Metab 2014;64:167–78. 10.1159/000363510
    1. Guess N, Perreault L, Kerege A et al. . Dietary fatty acids differentially associate with fasting versus 2-hour glucose homeostasis: implications for the management of subtypes of prediabetes. PLoS One 2016;11:e0150148 10.1371/journal.pone.0150148
    1. Teixeira SR, Potter SM, Weigel R et al. . Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000;71:1077–84.
    1. Aso T, Uchiyama S, Matsumura Y et al. . A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. J Womens Health (Larchmt) 2012;21:92–100. 10.1089/jwh.2011.2753
    1. Babio N, Becerra-Tomás N, Martínez-González MÁ et al. . Consumption of yogurt, low-fat milk, and other low-fat dairy products is associated with lower risk of metabolic syndrome incidence in an elderly Mediterranean population. J Nutr 2015;145:2308–16. 10.3945/jn.115.214593
    1. Esposito K, Maiorino MI, Bellastella G et al. . Mediterranean diet for type 2 diabetes: cardiometabolic benefits. Endocrine 2016:1–6.
    1. Ballard KD, Mah E, Guo Y et al. . Low-fat milk ingestion prevents postprandial hyperglycemia-mediated impairments in vascular endothelial function in obese individuals with metabolic syndrome. J Nutr 2013;143:1602–10. 10.3945/jn.113.179465
    1. Abedini M, Falahi E, Roosta S. Dairy product consumption and the metabolic syndrome. Diabetes Metab Syndr 2015;9:34–7. 10.1016/j.dsx.2014.04.027
    1. O'Connor LM, Lentjes MA, Luben RN et al. . Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 2014;57:909–17. 10.1007/s00125-014-3176-1
    1. Cândido FG, Ton WT, Alfenas Rde C. Dairy products consumption versus type 2 diabetes prevention and treatment; a review of recent findings from human studies. Nutr Hosp 2013;28:1384–95. 10.3305/nh.2013.28.5.6704
    1. Aune D, Norat T, Romundstad P et al. . Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 2013;98:1066–83. 10.3945/ajcn.113.059030
    1. Messina M, Messina V. The role of soy in vegetarian diets. Nutrients 2010;2:855–88. 10.3390/nu2080855
    1. Rosell MS, Appleby PN, Spencer EA et al. . Soy intake and blood cholesterol concentrations: a cross-sectional study of 1033 pre- and postmenopausal women in the Oxford arm of the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2004;80:1391–6.
    1. Yang G, Shu XO, Jin F et al. . Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr 2005;81:1012–17.
    1. Villegas R, Gao YT, Yang G et al. . Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 2008;87:162–7.
    1. Erdman JW., Jr AHA science advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000;102:2555–9. 10.1161/01.CIR.102.20.2555
    1. Liu ZM, Chen YM, Ho SC. Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2011;93:1092–101. 10.3945/ajcn.110.007187
    1. Wakai K, Egami I, Kato K et al. . Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 1999;33:139–45. 10.1207/S15327914NC330204
    1. Konig D, Deibert P, Frey I et al. . Effect of meal replacement on metabolic risk factors in overweight and obese subjects. Ann Nutr Metab 2008;52:74–8. 10.1159/000119416
    1. Liu ZM, Ho SC, Chen YM et al. . Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women. Mol Nutr Food Res 2014;58:709–17. 10.1002/mnfr.201300499
    1. Gao D, Ning N, Wang C et al. . Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One 2013;8:e73965 10.1371/journal.pone.0073965
    1. Takatsuka N, Nagata C, Kurisu Y et al. . Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev Med 2000;31:308–14. 10.1006/pmed.2000.0714
    1. Welty FK, Lee KS, Lew NS et al. . Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 2007;167:1060–7. 10.1001/archinte.167.10.1060
    1. Azadbakht L, Kimiagar M, Mehrabi Y et al. . Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 2007;85:735–41.
    1. Behavioural Risk Factor Survey. Commissioned by Surveillance and Epidemiology Branch, Centre for Health Protection, Department of Health, April 2007:40–1.
    1. Messina M. Guidelines for Healthy Soy Intake. Soy Connection The United Soybean Board. .
    1. Ho SC, Woo JL, Leung SS et al. . Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J Nutr 2000;130:2590–3.
    1. Wang Y, Tao Y, Hyman ME et al. . Osteoporosis in China. Osteoporos Int 2009;20:1651–62. 10.1007/s00198-009-0925-y
    1. Ge K. The transition of Chinese dietary guidelines and food guide pagoda. Asia Pac J Clin Nutr 2011;20:439–46.
    1. Grundy SM, Cleeman JI, Merz CN et al. . Implications of recent clinical trials for The National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227–39. 10.1161/01.CIR.0000133317.49796.0E
    1. Messina M. Investigating the optimal soy protein and isoflavone intakes for women: a perspective. Womens Health (Lond) 2008;4:337–56. 10.2217/17455057.4.4.337
    1. Rodriguez-Cano A, Mier-Cabrera J, Balas-Nakash M et al. . Dietary changes associated with improvement of metabolic syndrome components in postmenopausal women receiving two different nutrition interventions. Menopause 2015;22:758–64. 10.1097/GME.0000000000000400
    1. Oba S, Nagata C, Shimizu N et al. . Soy product consumption and the risk of colon cancer: a prospective study in Takayama, Japan. Nutr Cancer 2007;57:151–7. 10.1080/01635580701274475
    1. Mahan LK, Escott-Stump S. Krauses food nutrition and diet therapy. 11th edn Philadelphia: WB Saunders, 2004:1267–8.
    1. Liu ZM, Ho SC, Chen YM et al. . Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: a 6-month randomized controlled trial among postmenopausal women. J Hypertens 2013;31:384–92. 10.1097/HJH.0b013e32835c0905
    1. Liu ZM, Ho SC, Chen YM et al. . A mild favorable effect of soy protein with isoflavones on body composition--a 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal women. Int J Obes (Lond) 2010;34:309–18. 10.1038/ijo.2009.236
    1. Liu ZM, Ho SC, Chen YM et al. . The effects of isoflavones combined with soy protein on lipid profiles, C-reactive protein and cardiovascular risk among postmenopausal Chinese women. Nutr Metab Cardiovasc Dis 2012;22:712–19. 10.1016/j.numecd.2010.11.002
    1. Liu ZM, Ho SC, Chen YM et al. . A six-month randomized controlled trial of whole soy and isoflavones daidzein on body composition in equol-producing postmenopausal women with prehypertension. J Obes 2013;2013:359763 10.1155/2013/359763
    1. Wu Y, Liu X, Li X et al. . Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 2006;114:2217–25.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe